Matches in Wikidata for { <http://www.wikidata.org/entity/Q37123402> ?p ?o ?g. }
- Q37123402 description "article científic" @default.
- Q37123402 description "article scientifique" @default.
- Q37123402 description "articolo scientifico" @default.
- Q37123402 description "artigo científico" @default.
- Q37123402 description "artículu científicu espublizáu en 2008" @default.
- Q37123402 description "bilimsel makale" @default.
- Q37123402 description "bài báo khoa học" @default.
- Q37123402 description "scientific article published on April 2008" @default.
- Q37123402 description "vedecký článok" @default.
- Q37123402 description "vetenskaplig artikel" @default.
- Q37123402 description "videnskabelig artikel" @default.
- Q37123402 description "vědecký článek" @default.
- Q37123402 description "wetenschappelijk artikel" @default.
- Q37123402 description "wissenschaftlicher Artikel" @default.
- Q37123402 description "наукова стаття, опублікована у квітні 2008" @default.
- Q37123402 description "научни чланак" @default.
- Q37123402 description "مقالة علمية نشرت في أبريل 2008" @default.
- Q37123402 name "Emerging role for the vitamin D receptor activator (VDRA), paricalcitol, in the treatment of secondary hyperparathyroidism" @default.
- Q37123402 name "Emerging role for the vitamin D receptor activator (VDRA), paricalcitol, in the treatment of secondary hyperparathyroidism" @default.
- Q37123402 name "Emerging role for the vitamin D receptor activator (VDRA), paricalcitol, in the treatment of secondary hyperparathyroidism" @default.
- Q37123402 type Item @default.
- Q37123402 label "Emerging role for the vitamin D receptor activator (VDRA), paricalcitol, in the treatment of secondary hyperparathyroidism" @default.
- Q37123402 label "Emerging role for the vitamin D receptor activator (VDRA), paricalcitol, in the treatment of secondary hyperparathyroidism" @default.
- Q37123402 label "Emerging role for the vitamin D receptor activator (VDRA), paricalcitol, in the treatment of secondary hyperparathyroidism" @default.
- Q37123402 prefLabel "Emerging role for the vitamin D receptor activator (VDRA), paricalcitol, in the treatment of secondary hyperparathyroidism" @default.
- Q37123402 prefLabel "Emerging role for the vitamin D receptor activator (VDRA), paricalcitol, in the treatment of secondary hyperparathyroidism" @default.
- Q37123402 prefLabel "Emerging role for the vitamin D receptor activator (VDRA), paricalcitol, in the treatment of secondary hyperparathyroidism" @default.
- Q37123402 P1433 Q37123402-93C4F4D3-EC7A-4A45-99E1-C6E4DD37F9A7 @default.
- Q37123402 P1476 Q37123402-A7AA6578-5D3F-4D22-B5C8-9047A92628C5 @default.
- Q37123402 P2093 Q37123402-69E8758D-0B12-47BD-A373-C6C1F698D44B @default.
- Q37123402 P2860 Q37123402-099201C3-2468-4C7F-B9D2-5CA8CB0C2EC4 @default.
- Q37123402 P2860 Q37123402-0E515996-EB8C-406A-8A20-0C197FD4151F @default.
- Q37123402 P2860 Q37123402-12A25FEA-DCCE-4619-AB37-D8DFADDBE788 @default.
- Q37123402 P2860 Q37123402-2BD0F3E1-AC62-4C68-9F6D-6484ECDBE722 @default.
- Q37123402 P2860 Q37123402-4EDF3E07-09F9-4D17-8BF4-CBCA38F53C62 @default.
- Q37123402 P2860 Q37123402-55A9B387-A240-49DB-806F-FDAA68A50FA8 @default.
- Q37123402 P2860 Q37123402-5A8FB2AF-CD20-425E-935B-B800CDD9CD7F @default.
- Q37123402 P2860 Q37123402-5D542123-CB54-4676-AEFF-C500D88E7721 @default.
- Q37123402 P2860 Q37123402-6707DCE2-6CDB-4DB3-BD6E-2EFC42D5E822 @default.
- Q37123402 P2860 Q37123402-7160953D-D7B9-4E27-97F8-A2FD1089E19A @default.
- Q37123402 P2860 Q37123402-75F3A77D-D155-4CB4-BFA7-931FBCA6FE7E @default.
- Q37123402 P2860 Q37123402-805E1DE9-A01E-490C-94B8-25279A2F7246 @default.
- Q37123402 P2860 Q37123402-8438FA1A-E57E-4B88-909D-2049A7821CC7 @default.
- Q37123402 P2860 Q37123402-853AA77D-32C6-4D66-9588-AABCE57A2D58 @default.
- Q37123402 P2860 Q37123402-8B0FF1E2-3553-48DB-A5D2-7D49A75F8F89 @default.
- Q37123402 P2860 Q37123402-8E2E407A-D125-4D04-9432-B049E89C404E @default.
- Q37123402 P2860 Q37123402-8E43215C-7EEB-46AE-B7FB-2BA23978AE8B @default.
- Q37123402 P2860 Q37123402-97DA6A18-B55B-4B2C-BCAB-11333D33E73E @default.
- Q37123402 P2860 Q37123402-9FBDE00F-E062-4973-B23A-6CB24F623DA2 @default.
- Q37123402 P2860 Q37123402-A095D604-2828-44A7-B03D-E01BFE146356 @default.
- Q37123402 P2860 Q37123402-A16C6C38-9AE3-4B0D-9FAE-C90311E75E58 @default.
- Q37123402 P2860 Q37123402-B936D5CD-1F66-4849-A2B3-76658D3F171C @default.
- Q37123402 P2860 Q37123402-B9418126-1B13-4575-9A3B-44D9D452121B @default.
- Q37123402 P2860 Q37123402-C62C90D9-04EF-4D03-ACA5-5750AD883A39 @default.
- Q37123402 P2860 Q37123402-CFE00B48-04EC-40AF-AF07-C982109D57CB @default.
- Q37123402 P2860 Q37123402-DA0C5E09-49C0-4982-A120-A54C64029D5C @default.
- Q37123402 P2860 Q37123402-E1D780B3-559C-42F8-A92C-0491597401DC @default.
- Q37123402 P2860 Q37123402-EA126FEA-B0C3-4F9F-BDE7-2D0AAA189AF2 @default.
- Q37123402 P2860 Q37123402-ED7CC2CC-2DE1-4C1C-AB06-0C0F16D414CE @default.
- Q37123402 P2860 Q37123402-FDB0BD00-14B3-492C-ADB2-40643C8E1AB7 @default.
- Q37123402 P304 Q37123402-9E2E3730-D14E-4549-8545-BCB392CBB422 @default.
- Q37123402 P31 Q37123402-76e19dd2-46c7-4c0a-a581-1d75ad7e20b5 @default.
- Q37123402 P31 Q37123402-B6B1F02A-25D4-4542-B28C-34ED68C76451 @default.
- Q37123402 P356 Q37123402-115DB798-2766-4B16-B1AC-5457C44836C3 @default.
- Q37123402 P407 Q37123402-DFA6F572-2BB8-46BA-80B9-DFA0CDF0DB36 @default.
- Q37123402 P433 Q37123402-B8984859-DE5F-44C4-A35F-E08DA7405BAB @default.
- Q37123402 P478 Q37123402-128A4B95-A6EE-49A9-A1C7-685A93DA35B8 @default.
- Q37123402 P50 Q37123402-157EDF73-D6E3-4F38-8088-2132136002DF @default.
- Q37123402 P577 Q37123402-914BB0F2-6B5E-4B11-8729-D746E62B8D17 @default.
- Q37123402 P698 Q37123402-428D8226-1851-4531-AC1E-E26443DDF37D @default.
- Q37123402 P921 Q37123402-3a5c9f66-3ef6-4d06-8fce-91fd9b9a5d32 @default.
- Q37123402 P921 Q37123402-44D4BBC6-2E04-496F-ABB1-04D4E18A798C @default.
- Q37123402 P921 Q37123402-D1569093-658D-42BB-9510-2C63F7BC9DC1 @default.
- Q37123402 P356 14656566.9.6.947 @default.
- Q37123402 P698 18377338 @default.
- Q37123402 P1433 Q5421212 @default.
- Q37123402 P1476 "Emerging role for the vitamin D receptor activator (VDRA), paricalcitol, in the treatment of secondary hyperparathyroidism" @default.
- Q37123402 P2093 "Diego Brancaccio" @default.
- Q37123402 P2860 Q33828099 @default.
- Q37123402 P2860 Q33939147 @default.
- Q37123402 P2860 Q34262129 @default.
- Q37123402 P2860 Q34437598 @default.
- Q37123402 P2860 Q34571933 @default.
- Q37123402 P2860 Q34648670 @default.
- Q37123402 P2860 Q35018712 @default.
- Q37123402 P2860 Q35206257 @default.
- Q37123402 P2860 Q35822326 @default.
- Q37123402 P2860 Q36117940 @default.
- Q37123402 P2860 Q36192817 @default.
- Q37123402 P2860 Q41056211 @default.
- Q37123402 P2860 Q41521915 @default.
- Q37123402 P2860 Q42163977 @default.
- Q37123402 P2860 Q42197283 @default.
- Q37123402 P2860 Q42438588 @default.
- Q37123402 P2860 Q43818206 @default.
- Q37123402 P2860 Q44007634 @default.
- Q37123402 P2860 Q44039636 @default.
- Q37123402 P2860 Q44104172 @default.
- Q37123402 P2860 Q44111648 @default.
- Q37123402 P2860 Q44137797 @default.